Profile for TG Therapeutics Inc. (TGTX)

$ 18.28   0.69 (+3.92%) Volume: 2.94m 4:00 PM EDT Jun 5, 2020
After Hours:  $ 18.28 0.00 (0.00%) Volume: 39.91k 6:04 PM EDT Jun 5, 2020
Business Description:
TG Therapeutics Inc is a biopharmaceutical company. It is engaged in the acquisition, development & commercialization of novel treatments for B-cell malignancies and autoimmune diseases.
Address: 2 Gansevoort Street, 9th Floor, New York, NY, USA, 10014
Telephone: +1 212 554-4484 Website: http://www.tgtherapeutics.com
Facsimile: +1 212 554-4531 Email: [email protected]
Details
CEO: Michael S. Weiss
Employees: 134 Market Cap: 2.1b
Issue Type: CS
Auditor: CohnReznick LLP
Last Audit: Unqualified Opinion with Explanation
Indices: N/A
Industry Classifications
Sector: Healthcare CIK: 1001316
Industry: Biotechnology
Sub-Industry:    Biotechnology
NAICS: Pharmaceutical Preparation Manufacturing (325412)
SIC: Pharmaceutical Preparations (2834)